Skip to main content
. 2012 Jan 18;7(1):e29848. doi: 10.1371/journal.pone.0029848

Table 2. Breakdown of genotyped samples by Illumina SNP array type (columns 3—7), laboratory (column 8), and case/control/study status (rows).

370 610 1 M 300 550 Lab
Centenarians NECS 583 102 176 0 0 BU
ELIXIR 209 44 0 0 0 BU
Controls NECS 237 4 0 0 0 BU
Illumina I 0 0 0 89 584 unknown
Illumina II 0 0 0 62 279 unknown
Illumina III 0 0 0 574 2289 unknown
Coriell NINDs 867 0 0 0 0 CIDR

The columns of the table denote the Illumina array types. The column “Lab” denotes the laboratory that performed the genotyping: BU = Boston University; CIDR = Center for Inherited Disease Research. The row Illumina I denotes the control samples included in the discovery set; Illumina II denotes the control samples included in the first replication set, and Illumina III denotes the residual samples from the Illumina repository; Coriell NINDs denotes the neurologically normal controls.